BMS-986490, Bevacizumab — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-09-05 in 3mo
ESTIMATED |
READOUT
A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors
Phase 1/2 · Advanced Solid Tumors |
BMY BRISTOL MYERS SQUIBB CO | BMS-986490, Bevacizumab |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|